By www.reliablemarketsize.com
Global And United States Polycythemia Vera Drug Market Report & Forecast 2024-2031 Story
105
$ 4350
Polycythemia Vera Drug Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
ANP Technologies, Inc. Bristol-Myers Squibb Company F. Hoffmann-La Roche Ltd. Galena Biopharma, Inc. Gilead Sciences, Inc. Italfarmaco S.p.A. Karus Therapeutics Limited miRagen Therapeutics, Inc. Nerviano Medical Sciences S.r.l. Novartis AG PharmaEssentia Corporation Teva Pharmaceutical Industries Ltd.